EUVIMEDEUVIMED entdecken
Crossref

Beta-Catenin Alterations in Postchemotherapy Yolk Sac Tumor, Postpubertal-Type With Enteroblastic Features

Ahmet Surucu, Dario de Biase, Costantino Ricci, Luisa di Sciascio, Katrina Collins, Muhammad T Idrees, Kingsley Ebare, Michelangelo Fiorentino, Julia A Bridge, Thomas M Ulbright, Andres M Acosta

Modern Pathology · 2024-07 · 37 (7) · 100513

DOI: 10.1016/j.modpat.2024.100513 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024-07. Verfasst von Ahmet Surucu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Indiana University, Indianapolis, Indiana. Hauptthemen laut MEDLINE: beta Catenin, Endodermal Sinus Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Stanford University, Indiana University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postchemotherapy postpubertal-type yolk sac tumors (YST) with glandular and solid phenotypes are aggressive and commonly resistant to systemic chemotherapy. These neoplasms show morphologic features that significantly overlap with those of somatic carcinomas with "enteroblastic" or "fetal" phenotype (the preferred terminology depends on the site of origin). They often present as late or very late recurrences, and their diagnosis is challenging because they frequently affect patients in an age group at risk for carcinomas of somatic origin. Recently, we incidentally identified examples of postchemotherapy glandular and solid YST with "enteroblastic" phenotypes and nuclear expression of beta-catenin, prompting us to further evaluate the prevalence of this phenomenon. We found nuclear expression of beta-catenin in 10 (29%) of 34 such tumors. A subset of cases with nuclear beta-catenin expression was further analyzed with a DNA sequencing panel (n = 6) and fluorescence in situ hybridization for isochromosome 12p [i(12p); n = 5]. Sequencing identified exon 3 CTNNB1 variants in 3 (50%) of 6 analyzed cases, and fluorescence in situ hybridization was positive for i(12p) in 5 of 5 cases. In conclusion, a significant subset of postchemotherapy YST with glandular or solid architecture and "enteroblastic" phenotype demonstrates beta-catenin alterations, suggesting that activation of Wnt signaling may play a role in the progression of these neoplasms. Moreover, nuclear beta-catenin expression in these tumors represents a potential diagnostic pitfall given that carcinomas of true somatic origin with overlapping morphology may also be positive for this marker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta CateninEndodermal Sinus TumorHumansFemaleMaleIn Situ Hybridization, FluorescenceChildChild, PreschoolAdolescentBiomarkers, TumorAdultYoung AdultInfantPhenotype

Stichwörter der Autor:innen

beta-cateninenteroblasticgerm cell tumortestisyolk sac tumor

Substanzen

beta CateninCTNNB1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Indiana University, Indianapolis, Indiana.
  • Department of Pathology, Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Pharmacy and Biotechnology (FaBit), University of Bologna, Bologna,…
  • DIAP-Dipartimento InterAziendale di Anatomia Patologica di Bologna, Maggiore Hospital-AUSL Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
  • Department of Pathology, Mayo Clinic Arizona, Scottsdale, Arizona.
  • Department of Pathology, University of Nebraska Medical Center, Omaha, Nebraska; Cytogenetics and Fluorescence In Situ Hybridization, ProPath Laboratories, Dallas, Texas.
  • Department of Pathology, Indiana University, Indianapolis, Indiana. Electronic address: anmaacos@iu.edu.

Förderung

  • Stanford University
  • Indiana University

Zitieren

APA

Surucu, A., de Biase, D., Ricci, C., di Sciascio, L., Collins, K., Idrees, M. T., Ebare, K., Fiorentino, M., Bridge, J. A., Ulbright, T. M., & Acosta, A. M. (2024). Beta-Catenin Alterations in Postchemotherapy Yolk Sac Tumor, Postpubertal-Type With Enteroblastic Features. Modern Pathology, 37(7), 100513. https://doi.org/10.1016/j.modpat.2024.100513

Vancouver

Surucu A, de Biase D, Ricci C, di Sciascio L, Collins K, Idrees MT, et al. Beta-Catenin Alterations in Postchemotherapy Yolk Sac Tumor, Postpubertal-Type With Enteroblastic Features. Modern Pathology. 2024;37(7):100513. doi:10.1016/j.modpat.2024.100513

BibTeX
@article{Surucu2024,
  author = {Surucu, Ahmet and de Biase, Dario and Ricci, Costantino and di Sciascio, Luisa and Collins, Katrina and Idrees, Muhammad T and Ebare, Kingsley and Fiorentino, Michelangelo and Bridge, Julia A and Ulbright, Thomas M and Acosta, Andres M},
  title = {Beta-Catenin Alterations in Postchemotherapy Yolk Sac Tumor, Postpubertal-Type With Enteroblastic Features},
  journal = {Modern Pathology},
  year = {2024},
  volume = {37},
  number = {7},
  pages = {100513},
  doi = {10.1016/j.modpat.2024.100513}
}
Kostenlos starten →